Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans

British Journal of Anaesthesia

Volumn 79, Issue 5, 1997, Pages 600-605

  Ilkjaer S ^a   Dirks, J ^b   Brennum, J ^c   Wernberg, M ^a   Dahl, J B ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

Model, burn injury; Pain, mechanism; Pain, postoperative; Pharmacology, dextromethorphan

Indexed keywords

DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HYPERALGESIA; MALE; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD DORSAL HORN; STROKE; VERTIGO;

EID: 0030730577     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/79.5.600     Document Type: Article

References (33)

1. Yaksh TL. The spinal pharmacology of facilitation of afferent processing evoked by high-threshold afferent input of the postinjury pain state. Current Opinion in Neurology and Neurosurgery 1993; 6: 250-256.
2. Dickenson AH. Spinal cord pharmacology of pain. British Journal of Anaesthesia 1995; 75: 193-200.
3. Woolf CJ. Central mechanisms of acute pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth World Congress on Pain. Amsterdam: Elsevier, 1991; 25-34.
4. Woolf CJ. Somatic pain-pathogenesis and prevention. British Journal of Anaesthesia 1995; 75: 169-176.
5. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fibre stimulation. Neuropharmacology 1987; 26: 1235-1238.
6. Davies SN, Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Research 1987; 424: 402-406.
7. Dickenson AH. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends in Pharmacological Sciences 1990; 11: 307-309.
8. Dickenson AH, Sullivan AF. Differential effects of excitatory amino-acid antagonists on dorsal horn nociceptive neurons in the rat. Brain Research 1990; 506: 31-39.
9. Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. British Journal of Anaesthesia 1996; 76: 829-834.
10. Price D.D, Mao J, Frenk H, Mayer DJ. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59: 165-174.
11. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995; 63: 163-172.
12. Tortella FC, Pellicano M, Bowery NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends in Pharmacological Sciences 1989; 10: 501-507.
13. Dickenson AH, Sullivan AF, Stanfa LC, McQuay HJ. Dextromethorphan and levorphanol on dorsal horn nociceptive neurones in the rat. Neuropharmacology 1991; 30: 1303-1308.
14. Tal M, Bennett GJ. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neuroscience Letters 1993; 151: 107-110.
15. Elliot KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE. Dextromethorphan supresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995; 61: 401-409.
16. Bem JL, Peck R. Dextromethorphan - an overview of safety issues. Drug Safety 1992; 7: 190-199.
17. Treede RD, Meyer RA, Raja SN, Campell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Progress in Neurobiology 1992; 38: 397-421.
18. Baumann TK, Simone DA, Shain CN, LaMotte RH. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fiders that contribute to capsaicin-induced pain and hyperalgesia. Journal of Neurophysiology 1991; 66: 212-227.
19. LaMotte RH, Lundberg LER, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. Journal of Physiology (London) 1992; 448: 749-764.
20. LaMotte, Shain CN, Simone DA, Tsai EFP. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. Journal of Neurophysiology 1991; 66: 190-211.
21. Simone DA, Sorkin LS, Oh O, Chung JM, Owens C, LaMotte RH, Willis WD. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. Journal of Neurophysiology 1991; 66: 228-246.
22. Torebjork E, Lundberg L, LaMotte R. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. Journal of Physiology (London) 1992; 448: 765-780.
23. Dahl JB, Brennum J, Arendt-Nielsen L, Jensen TS, Kehlet H. The effect of pre- versus postinjury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin. Pain 1993; 53: 43-51.
24. Brennum J, Dahl JB, Møiniche S, Arendt-Nielsen L. Quantitative sensory examination during epidural anaesthesia and analgesia in man. Effects of preemptive and posttraumatic morphine on hyperalgesia. Pain 1994; 59: 261-271.
25. Elliott K, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 1994; 59: 361-368.
26. Manning BH, Mao J, Frenk H, Price DD, Mayer DJ. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996; 67: 79-88
27. Price DD, Mao J, Lu J, Caruso FS, Frenk H, Mayer DJ. Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioural symptoms indicative of arthritic pain in rats. Pain 1996; 68: 119-127.
28. Dionne RA, Gordon SM, Brahim J, Dubner R. Evaluation of the NMDA receptor antagonist dextromethorphan in the oral surgery model. 8th World Congress on Pain, IASP, August 17-22, 1996. Vancouver, British Columbia, Canada; abstract No.117.
29. McQuay HJ, Caroll D, Jadad AR, Glynn CJ, Jack T, Moore RA, Wiffen PJ. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-I design. Pain 1994; 59: 127-133.
30. Kauppila T, Gronrooa M, Pertovaara A. An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist. Pharmacology, Biochemistry and Behavior 1995; 52: 641-644.
31. Hollander D, Pradas J, Kaplan R, McLeod HL, Evans WE, Munsat TL. High-dose dextromethorphan in amyotrophic lateral sclerosis: phase 1 safety and pharmacokinetic studies. Annals of Neurology 1994; 36: 920-924.
32. Albers GW, Sanez RE, Moses JA jr.Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Clinical Neuropharmacology 1992; 15: 509-514.
33. Cevero F, Gilbert R, Hammond RGE, Tanner J. Development of secondary hyperalgesia following non-painful thermal stimulation of the skin: a psychophysical study in man. Pain 1993; 54: 181-189.